Skip to NavigationSkip to content

News

Johnson & Johnson has revealed Phase 2 data for its treatment for depression, esketamine, and the results are positive - showing substantial...
Novartis has received a major boost in its efforts to broaden use of its CDK4/6 inhibitor, by receiving a breakthrough status from the FDA in...
Mallinckrodt has instigated a $1.2 billion acquisition of Sucampo Pharmaceuticals that will see it gain access to the latter company’s...
There was ample warning that the NHS looked set to face another difficult winter season, the predictions now look to have become reality as...
A group of researchers at Lancaster University have identified a drug currently used to treat type 2 diabetes that has shown potential benefit in the...
GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the US for marketing authorisation on its...
NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds, back in August 2017, but it has now revealed that NICE has agreed to return to...
Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device that uses shock...
Since Mylan and Biocon managed to gain US FDA approval for its Herceptin biosimilar, it has forged ahead in the global market to make up for time...
Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say the least, with the settlement of a...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches